Get the Stockscreener App
89.55
12.03%
-12.25
After Hours:
89.75
0.20
+0.22%
Billiontoone Inc stock is traded at $89.55, with a volume of 141.30K.
It is down -12.03% in the last 24 hours and up +0.00% over the past month.
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.
See More
Previous Close:
$101.80
Open:
$100.56
24h Volume:
141.30K
Relative Volume:
11.83
Market Cap:
$4.62B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$89.05
$102.03
1-Week Range:
$89.05
$110.00
52-Week Range:
$89.05
$110.00
Billiontoone Inc Stock (BLLN) Company Profile
Name
Billiontoone Inc
Sector
Industry
Phone
-
Address
-
Compare BLLN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
89.55 | 4.62B | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
580.13 | 220.92B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
221.20 | 154.97B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
701.48 | 56.98B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.89 | 42.96B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
223.55 | 37.62B | 15.90B | 1.28B | 2.21B | 7.2842 |
Billiontoone Inc Stock (BLLN) Latest News
BillionToOne SVP Johnson buys $414k in class A common stock By Investing.com - Investing.com South Africa
BillionToOne SVP Johnson buys $414k in class A common stock - Investing.com Australia
BillionToOne Insiders Make Bold Moves with Major Stock Purchases! - TipRanks
Rai Akshay buys billionToOne shares worth $150,000 By Investing.com - Investing.com UK
Rai Akshay buys billionToOne shares worth $150,000 - Investing.com
BillionToOne, Inc. Completes Successful IPO Raising $314 Million - The Globe and Mail
BillionToOne director Bremner buys $2.5 million in shares By Investing.com - Investing.com UK
BillionToOne director Bremner buys $2.5 million in shares - Investing.com
BillionToOne Transaction - William Blair
BillionToOne (BLLN): Reviewing the High Valuation After Recent Share Price Dip - Yahoo Finance
Evommune and BillionToOne climb on trading debut - MSN
BillionToOne, Inc. Closes Upsized Initial Public Offering Raising $314 Million on Nasdaq - Quiver Quantitative
BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - MarketScreener
BillionToOne valued at $4.4 billion as shares surge in blockbuster Nasdaq debut - WKZO
BillionToOne: A Deserved Opening Day Boom (NASDAQ:BLLN) - Seeking Alpha
Pair Of Health-Focused Startups Net $423M In Combined IPOs - Law360
BillionToOne raises $273.1 million in upsized IPO By Investing.com - Investing.com Nigeria
BillionToOne, Inc. (BLLN): Precision Diagnostics Firm Soars 82% in One of 2025’s Best IPO Debuts - Smartkarma
BillionToOne, Evommune Shares Climb in IPOs - The Wall Street Journal
How A Turkish Immigrant Engineered A Successful Diagnostics Startup IPO - Forbes
BillionToOne raises $273.1 million in upsized IPO - Investing.com India
BillionToOne shares rise on first day of trading - Axios
Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering - PR Newswire
BillionToOne (BLLN.US) went public on Nasdaq, surging 81.57% on its first day, with its market value rising to nearly USD 4.8 billion. - 富途牛牛
BillionToOne Shares Surge 82% After Upsized $273 Million IPO - Bloomberg.com
BillionToOne IPO becomes $5 billion explosion as Bay Area medical test maker's stock soars in debut - The Business Journals
Evommune and BillionToOne climb on trading debut (EVMN:NYSE) - Seeking Alpha
BillionToOne Shares Surge Following Firm's $273M IPO - GenomeWeb
BillionToOne shares soar 67% in Nasdaq debut, valuing firm at $4.4 billion - Investing.com Canada
BillionToOne raises $273.1m in IPO - Yahoo Finance
BillionToOne poised to open 66.7% above offer price in Nasdaq debut - TradingView
BillionToOne indicating open above $91, upsized IPO priced at $60 By Investing.com - Investing.com Philippines
Billiontoone shares surge after $273M upsized IPO - BioWorld MedTech
Evommune, BillionToOne set IPO price - MSN
Evommune and BillionToOne set IPO prices (EVMN:NYSE) - Seeking Alpha
Drug developer Evommune targets $150 million in IPO amid government shutdown - The Business Journals
BillionToOne raises $273M in IPO - Axios
BillionToOne prices upsized IPO at $60 per share, raising $273.1 million - Investing.com Philippines
BillionToOne Prices Upsized IPO at $60 Per Share on Nasdaq - parameter.io
Molecular diagnostics firm BillionToOne raises $273 million in US IPO - MSN
BLLN IPO NewsMolecular diagnostics company BillionToOne prices upsized IPO at $60, above the range - renaissancecapital.com
BillionToOne Prices IPO At $60 Per Share - RTTNews
BillionToOne prices upsized IPO at $60 per share By Investing.com - Investing.com Philippines
Molecular Diagnosis Firm BillionToOne Raises $273 Million in IPO - Bloomberg.com
BillionToOne prices upsized IPO at $60 per share - Investing.com India
Billiontoone Inc Stock (BLLN) Financials Data
There is no financial data for Billiontoone Inc (BLLN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.39%
2.08%
Cap:
|
Volume (24h):